Kingworld Medicines Group Ltd. ( (HK:1110) ) has provided an update.
Kingworld Medicines Group Ltd. has announced its annual general meeting scheduled for May 29, 2025, where shareholders will consider several resolutions, including the adoption of audited financial statements for 2024, the declaration of a final dividend, and the re-election of directors. Additionally, the company seeks approval to issue additional shares, which could impact its market positioning and shareholder value.
More about Kingworld Medicines Group Ltd.
Kingworld Medicines Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is primarily focused on the distribution and retail of medicines and healthcare products, with a market presence in Hong Kong.
YTD Price Performance: 10.87%
Average Trading Volume: 1,248,594
Technical Sentiment Signal: Hold
Current Market Cap: HK$303.2M
For detailed information about 1110 stock, go to TipRanks’ Stock Analysis page.